Skip to main content
. 2013 Apr;57(4):1938–1940. doi: 10.1128/AAC.01461-12

Table 2.

Colistin concentration-time data for the different study groupsa

Study group Day Time (h) No. of samples Mean ± SD (ng/ml) (range)
CSF/serum ratio
Serum CSF
Control 1 1 5 2,308 ± 348 152 ± 18 0.066 ± 0.002
4 5 1,491 ± 74 105 ± 11 0.070 ± 0.006
8 5 1,041 ± 135 76 ± 11 0.074 ± 0.002
3 1 3 2,039 ± 4 141 ± 17 0.069 ± 0.001
8 1 1,033 72 0.070
5 1 1 2,013 137 0.068
EVDViv 1 1 2 2,189 (1,922–2,455) 237 (198–275) 0.108
4 2 1,451 (1,405–1,498) 156 (152–159) 0.107
8 2 1,089 (930–1,248) 120 (103–137) 0.110
3 1 2 2,205 (2,097–2,313) 254 (213–295) 0.114
8 2 1,001 (970–1,032) 119 (117–120) 0.118
5 1 1 2,449 259 0.106
8 1 1,258 140 0.111
EVDVcomb 1 1 3 3,451 ± 221 1,449 ± 124 0.420 ± 0.012
4 1 1,838 838 0.456
8 1 1,523 621 0.408
3 1 1 3,144 1,357 0.432
5 1 3 3,531 ± 202 1,430 ± 40 0.406 ± 0.012
8 2 1,514 (1,415–1,612) 611 (548–675) 0.403
a

Data are presented as means ± SD or as otherwise indicated. EVDViv, external ventricular drainage-associated ventriculitis patients treated with i.v. colistin; EVDVcomb, external ventricular drainage-associated ventriculitis patients treated with combined i.v. and intraventricular colistin.